⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VERA News
Vera Therapeutics, Inc. Class A Common Stock
Obsidian Therapeutics Appoints Julie Feder as Chief Financial Officer
businesswire.com
AURA
VERA
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VERA
Vera Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
VERA
Vera Therapeutics Announces U.S. FDA Granted Priority Review to Biologics License Application for Atacicept for Treatment of Adults with IgA Nephropathy
globenewswire.com
VERA
Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock
globenewswire.com
VERA
Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
globenewswire.com
VERA
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
VERA
Vera Therapeutics Appoints Veteran Biotech Executive James R. Meyers to its Board of Directors
globenewswire.com
VERA
GILD
SANG
CTMX
Vera Therapeutics to Participate at Upcoming Investor Conferences
globenewswire.com
VERA
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
globenewswire.com
VERA